Orbifloxacin Tablets
33 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
33
Total Reports
7
Deaths Reported
2120.0%
Death Rate
Active Ingredients
Orbifloxacin Tablets
Administration Routes
OralUnknown
Species Affected
Dog 13
Unknown 12
Cat 8
Most Affected Breeds
Unknown 12
Domestic Shorthair 6
Crossbred Canine/dog 3
Pit Bull 2
Cat (unknown) 1
Shih Tzu 1
Russian 1
Pug 1
Chihuahua 1
Dog (unknown) 1
Most Reported Reactions
Lot # and /or Expiration date missing 9
Lethargy (see also Central nervous system depression in 'Neurological') 6
Product problem 4
Death by euthanasia 4
Seizure NOS 3
Dilated pupils 3
Elevated serum alkaline phosphatase (SAP) 3
Tablets, Abnormal 3
Blindness 3
Product label issues 3
Leucocytosis NOS 2
Anorexia 2
Outcome Breakdown
Ongoing
6 (28.6%)
Euthanized
5 (23.8%)
Outcome Unknown
3 (14.3%)
Recovered with Sequela
3 (14.3%)
Died
2 (9.5%)
Recovered/Normal
2 (9.5%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.